Lexaria Bioscience Corp. (LEXX)

Lexaria Bioscience Revenue

Lexaria Bioscience had revenue of $194.00K in the twelve months ending May 31, 2026, down -68.50% year-over-year. In the fiscal year ending August 31, 2025, Lexaria Bioscience had annual revenue of $705.92K with 52.05% growth. That makes Lexaria Bioscience the 45,519th largest company in the world by revenue and 6,640th in the United States.

• Revenue (ttm): $194.00K
• Revenue Growth: -68.50%
• P/S Ratio: 33.34
• Revenue / Employee: $27,714
• Employees: 7
• Market Cap: 6.78M

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Intellectual Property Licensing 696.00K 98.6%
• B2B Product 9.92K 1.4%

Fiscal year ended Aug 31, 2025 See the full Lexaria Bioscience breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Aug 31, 2025	705.92K	241.65K	52.05%
Aug 31, 2024	464.28K	238.07K	105.24%
Aug 31, 2023	226.21K	-29.19K	-11.43%
Aug 31, 2022	255.40K	-467.34K	-64.66%
Aug 31, 2021	722.74K	407.95K	129.59%
Aug 31, 2020	314.79K	92.18K	41.41%
Aug 31, 2019	222.61K	-210.68K	-48.62%
Aug 31, 2018	433.29K	369.65K	580.85%
Aug 31, 2017	63.64K	22.92K	56.29%
Aug 31, 2016	40.72K	26.02K	176.96%
Aug 31, 2015	14.70K	-	-
Aug 31, 2014	-	-	-
Oct 31, 2013	1.10M	-260.31K	-19.17%
Oct 31, 2012	1.36M	224.00K	19.76%
Oct 31, 2011	1.13M	771.30K	212.79%
Oct 31, 2010	362.47K	-59.48K	-14.10%
Oct 31, 2009	421.96K	-478.83K	-53.16%
Oct 31, 2008	900.79K	647.64K	255.83%
Oct 31, 2007	253.15K	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Jul 13, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue segment data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Oct 27, 2026

Data Sources Report a data error